This suggests that TGFβ should not be associated with disorders characteristic of systemic sclerosis, such as angiogenesis disorders: these may be more associated with Vascular Endothelium Growth Factor (VEGF), which is present at higher levels in patients with systemic sclerosis. The gene discussed is TGFB1; the disease is systemic sclerosis.